Park Ha Biological Technology , Ltd. Profit Margin

Park Ha Biological Technology , Ltd. (PHH) currently reports a profit margin of -44.44% as of June 2018. That compares with -55.96% in the prior-year period — up 20.6% year over year. That is below the sector sector average of 13.16%. Use the charts on this page to explore Park Ha Biological Technology , Ltd.'s profit margin history and peer comparisons.

Park Ha Biological Technology , Ltd.'s profit margin increased from -55.96% to -44.44% — a 20.6% year-over-year increase (period ending June 2018). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Park Ha Biological Technology , Ltd.'s profit margin of -44.44% is lower than the its sector sector average of 13.16%. That is roughly 437.6% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Park Ha Biological Technology , Ltd.'s current -44.44% should be judged against industry norms (sector average: 13.16%) and against PHH's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -44.44%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 13.16%. From there, open related valuation or income-statement pages for Park Ha Biological Technology , Ltd., and consider following PHH for alerts when major investors trade the stock.